Novo Resources Corp (TSX:NVO, OTCQX:NSRPF, ASX:NVO, FRA:1NOR) has confirmed a significant hydrothermal alteration system at its Wyloo Polymetallic Project in Western Australia’s Pilbara, following maiden reverse circulation drilling that returned high-grade silver and antimony mineralisation from surface.
The 16-hole, 2,615-metre program at the Wyloo SE prospect delivered a standout intercept of 9 metres at 92 g/t silver and 1,280 ppm antimony from surface, including 1 metre at 460 g/t silver and 1,425 ppm antimony from 2 metres.
Drilling also encountered broad zinc mineralisation, including 3 metres at 3.6% zinc, with a peak one-metre assay of 6.5% zinc, within a wider 27-metre mineralised halo.
Drilling validates Wyloo exploration model The program tested mapped quartz-sulphide veining and the northeast-southwest-trending Tasha Fault Zone across seven drill sections.
Novo identified strong sericite and chlorite alteration zones of up to 20 metres thick, accompanied by sulphide mineralisation and highly anomalous arsenic.
Silver, antimony and zinc mineralisation has now been recorded across a 230-metre strike length, supporting the company’s interpretation that Wyloo SE forms part of a broader mineralised system rather than an isolated occurrence.
Novo Pilbara and Onslow District tenure showing significant prospects and location of the Wyloo Project in the southern Pilbara.
Vera anomaly expands project footprint Surface sampling southeast of the drilling has also identified the Vera prospect, where a coherent antimony-arsenic soil anomaly extends for about 600 metres and is up to 270 metres wide.
Peak soil assays returned 803 ppm antimony and 1,265 ppm arsenic, while rock-chip sampling produced results of up to 3.5% antimony, 33.2 g/t silver, 1.4% zinc and 2.1% lead.
Novo said the anomaly remains open to the north and east, significantly extending the prospective footprint beyond the current Wyloo SE drilling area.
The nearby Kavira prospect is another priority, hosting a 2.5-kilometre by 800-metre antimony stream-sediment anomaly beneath extensive transported cover.
Toolunga project expanded around IOCG targets Novo has also increased its Toolunga Copper-Gold Project footprint from 1,520 square kilometres to 2,242 square kilometres through new tenement applications and optioned ground.
Reprocessed magnetic and gravity datasets have defined three high-priority iron oxide copper-gold-style targets at Lobster, Ironstone Bore and Mount Minnie.
The Lobster target covers an 8-kilometre by 4-kilometre magnetic-gravity complex, while Ironstone Bore contains an untested 2.5-kilometre by 2-kilometre anomaly. Mount Minnie hosts coincident geophysical targets and historical rock-chip results of up to 755 ppm copper.
Next steps Novo is undertaking hyperspectral analysis and geological modelling at Wyloo SE to identify vectors for follow-up drilling.
Further mapping, soil sampling and rock-chip work is planned at Vera during the third quarter of 2026, while an aircore drilling program at Kavira is targeted for the fourth quarter, subject to approvals.
At Toolunga, fieldwork will begin after the relevant tenements are granted, including ground gravity surveys, geochemical sampling and 3D modelling ahead of potential RC drilling.
Seven assay results from the company’s separate Cronus gold drilling program also remain pending, with results expected shortly.
SAN FRANCISCO--(BUSINESS WIRE)--After the final whistle blew on the FIFA World Cup 2026™, millions of fans returned home with unforgettable memories and a trail of economic activity that stretched across countries. Every tap to pay left a lasting impact, as spending throughout the tournament delivered a meaningful boost to merchants and local economies across host cities in Canada, Mexico and the United States. According to new data from Visa, the tournament drove significant growth in cross-bo.
Space is one of the most exciting investing themes going, but the ways to play it are frustrating. The buzziest names, like Jeff Bezos's Blue Origin, are private and off-limits to most people, and the one giant that went public, Space Exploration Technologies, trades at a dizzying valuation and swings wildly from day to day.
If you have $5,000 and want to put it somewhere sturdier, I would skip the space lottery tickets entirely and back a trillion-dollar consumer goods stock that quietly joined that elite club this year: Walmart (WMT 1.57%).
Image source: Getty Images.
The trouble with private space plays Private space companies make for great headlines -- and terrible portfolios for ordinary investors. You typically cannot buy them unless you are wealthy and connected; they are illiquid, and they are all-or-nothing bets on ventures that may take a decade to pay off, if they ever do.
Even SpaceX, now that it trades publicly, asks you to pay more than 100 times sales and ride out gut-wrenching volatility. That is a lot of speculation for a slice of a still-unproven business.
Today's Change
(
3.19
%) $
3.82
Current Price
$
123.67
Why Walmart is the smarter home for $5,000 Walmart crossed the $1 trillion mark this year. The company has quietly become a growth story. Its e-commerce sales have been climbing more than 20% a year, and its high-margin advertising arm, Walmart Connect, pulled in roughly $6.4 billion last fiscal year while growing far faster than the core retail business. Its Walmart+ membership program keeps adding subscribers and now counts around 30 million members, each one a recurring, sticky source of revenue.
That mix matters. Walmart pairs the defensive strength of selling groceries and essentials, a demand that holds up in any economy, with faster-growing, higher-margin digital businesses layered on top.
It is also a Dividend King, or a company that has at least 50 years of consecutive annual dividend increases. So your $5,000 collects growing income while you wait. And unlike a private space play, you can buy Walmart stock instantly and sell it just as easily.
Today's Change
(
-1.57
%) $
-1.77
Current Price
$
110.44
The catch worth naming I will be fair: Walmart is not going to shoot to the moon the way a successful space start-up might. Retail margins are thin, the stock recently slipped just below the trillion-dollar threshold, and a weaker consumer could pressure spending at the retail giant. You are trading explosive upside for durability and reliability. For some investors chasing a 10-bagger, that will feel too tame.
The smartest way to invest $5,000 is not always the flashiest. Private space plays offer a thrilling story but come with illiquidity, inaccessibility, and enormous risk. Walmart offers something rarer: a trillion-dollar business you can actually buy, with defensive staying power, real growth engines in e-commerce and advertising, and a rising dividend. Sometimes the sturdiest bet is also the smartest one, and this is a stock you can hold with confidence while the space hype comes and goes.
Earnings season has arrived once again, and last week, several major banks reported their second-quarter results.
Banks like JPMorgan Chase (JPM +1.88%) and Bank of America (BAC +1.32%) serve millions of American households and hold trillions in consumer deposits. These banks can help investors understand how Americans are spending their money, as well as the challenges some may face with debt and delinquency.
Here's what these bank earnings just revealed about the health of the American consumer right now.
Image source: Getty Images.
Consumers across the credit spectrum are holding up well There has been a lot of discussion about the K-shaped economy, which refers to a divergence in which high-income households are benefiting from rising wealth and spending, while lower-income groups face stagnant wages and inflation. The upper part of the K represents asset-rich consumers who profit from stock market gains, while the lower part represents those struggling with price increases amid persistent inflation, fueling fears of an economic slowdown.
In their earnings calls, bank executives have pushed back against the K-shaped recovery story, saying that consumers across the credit spectrum are holding up well. JPMorgan Chief Financial Officer Jeremy Barnum told investors during the company's Q2 earnings call that consumer spending is "robust and across income segments" and that its better-than-expected credit performance is visible "pretty much across the board by any kind of FICO score."
Today's Change
(
1.88
%) $
6.36
Current Price
$
345.23
If lower-income consumers were buckling, it would typically show up in late payments and depleted savings. However, Bank of America also reported that consumers remain resilient, with "average deposit investment balances and spending all showed linked quarter increases," according to CFO Alastair Borthwick.
Delinquencies are down while spending is up The data backs up what bankers are saying. In Q2, JPMorgan's net charge-off rate came in at 3.34%, down from 3.47% in Q1 and a 6-basis-point improvement from last year's Q2. This positive development has enabled the bank to lower its full-year net charge-off rate forecast to 3.2%. At Bank of America, the credit card charge-off rate was 3.55% for the quarter, down from 3.82% a year ago and 3.64% in the previous quarter.
Credit metrics are holding up well, as is spending. At JPMorgan, combined debit and credit card sales volumes increased by 10% year over year. At Bank of America, these volumes rose 9%.
Today's Change
(
1.32
%) $
0.80
Current Price
$
61.22
Bank executives attribute the strong performance to a couple of factors. Bank of America pointed to a stable labor market, with the unemployment rate hovering around 4.2% and new jobless claims remaining low. JPMorgan echoed the sentiment about a strong labor market and noted a positive tailwind from higher tax refunds in the quarter.
Resilient consumers should help support further economic growth Bankers said that consumers are performing well across the income and credit spectrum, though they admit some cohorts may still be struggling. During the Morgan Stanley U.S. Financials Conference in June, Marianne Lake, Chief Executive Officer of JPMorgan's consumer and community banking division, noted that a small group is seeing wages fail to keep pace with inflation.
Bank of America notes that wealthy clients are doing exceptionally well, as its global wealth and investment management division saw client balances jump 12% year over year to an all-time high of $4.9 trillion, leading to record revenue of $6.9 billion, a 16% increase year over year.
Banks continue to keep a close eye on inflation and on pockets of consumers experiencing falling real wages. That said, the American consumer remains strong and resilient. As unemployment remains relatively low and credit metrics improve, banks remain confident in extending credit, which should help support consumer spending and drive continued economic growth as we head into the second half of 2026.
Americká společnost GE Vernova, která vyrábí energetické zařízení a poskytuje služby, zveřejnila své výsledky hospodaření za druhý kvartál roku 2026. Divize energetiky a elektrifikace nadále těží z prudce rostoucí poptávky spojené mimo jiné s výstavbou datových center a modernizací rozvodných sítí, zatímco větrná energetika zůstává ztrátová. Díky silnému přílivu objednávek, expanzi marží a výrazné tvorbě hotovosti společnost navýšila svůj celoroční výhled pro rok 2026. Podle agentury Bloomberg investory zvýšený výhled nepřesvědčil, a to také vzhledem k letošnímu silnému růstu.
Výsledky společnosti GE Vernova (GEV) za 2Q 2026 2Q 2026 Konsensus 2Q 2026 2Q 2025 Tržby (mld. USD) 11,10 10,82 9,11 Čistý zisk (mld. USD) 0,65 -- 0,49 Zisk na akcii (EPS, USD/akcie) 2,47 -- 1,86 Výsledky Tržby zaznamenaly meziroční růst o 22 % na 11,10 mld. USD a překonaly konsensus ve výši 10,82 mld. USD. Organické tržby vzrostly o 12 % na 10,15 mld. USD.
Divize energetiky zaznamenala meziroční růst tržeb o 14 % na 5,48 mld. USD, když se očekávalo 5,56 mld. USD. Růst byl tažen zejména segmentem Gas Power díky vyššímu objemu aeroderivativních turbín, službám a příznivým cenám. Divize elektrifikace vykázala meziroční nárůst tržeb o 68 % na 3,64 mld. USD (organicky +29 %) při očekávání 3,38 mld. USD. Růst táhla silná poptávka po vybavení pro rozvodné sítě, zejména rozvaděčích, transformátorech a měnírnách. Výsledek zahrnuje také příspěvek z akvizice Prolec GE. Divizi větrné energetiky klesly tržby meziročně o 9,8 % na 2,03 mld. USD (organicky -11 %) při konsensu 1,87 mld. USD. Pokles byl způsoben nižšími dodávkami vybavení pro pevninské větrné elektrárny, částečně kompenzovanými růstem služeb a offshore projektů.
Očištěná EBITDA dosáhla 1,25 mld. USD (2Q 2025: 0,77 mld. USD), což mírně zaostalo za očekáváním ve výši 1,29 mld. USD. Očištěná EBITDA marže vzrostla meziročně o 280 bazických bodů na 11,3 %.
Segment energetiky vykázal segmentovou EBITDA 1,03 mld. USD při marži 18,8 %. Segment energetiky dosáhl segmentovou EBITDA 671 mil. USD při marži 18,4 %. Segment větrné energetiky zůstal ztrátový se segmentovou EBITDA –275 mil. USD (marže -13,6 %). Očištěné volné hotovostní toky (FCF) dosáhly 5,11 mld. USD oproti 194 mil. USD ve stejném období předešlého roku. K silnému výsledku výrazně přispěl kladný vliv provozního pracovního kapitálu, zejména nárůst smluvních závazků a záloh od zákazníků.
Objednávky zaznamenaly meziroční organický růst o 88 % na 24,2 mld. USD, tažené zejména segmenty energetiky a elektrifikace. Objednávky v segmentu energetiky vzrostly o 135 % na 16,73 mld. USD.
Nezpracované zakázky (backlog) mezikvartálně vzrostly o 13 mld. USD na celkových 176 mld. USD (meziročně +37 %).
Výhled Společnost zvýšila svůj celoroční výhled pro rok 2026 a nyní očekává:
Tržby ve výši 45,5 až 46,5 mld. USD, dříve projektovala 44,5 až 45,5 mld. USD. Očištěné volné hotovostní toky ve výši 11,5 až 12,5 mld. USD, dříve odhadovala 6,5 až 7,5 mld. USD. Očištěnou EBITDA marži nadále v rozmezí 12 až 14 %. V rámci jednotlivých divizí společnost projektuje organický růst tržeb segmentu energetiky o 18 % až 20 % (dříve projektovala 16 % až 18 %) při segmentové EBITDA marži 17% až 19 %, tržby segmentu elektrifikace ve výši 14,5 až 15,0 mld. USD (dříve 14,0 až 14,5 mld. USD) při segmentové EBITDA marži 18 % až 20 % a u segmentu větrné energetiky pokles organických tržeb v řádu nižších desítek procent (low-double-digits) s očekávanou segmentovou EBITDA ztrátou kolem 400 mil. USD.
Komentář CEO „Ve druhém kvartále jsme dosáhli silných finančních výsledků, neboť globální poptávka po našich produktech a řešeních nadále roste. S objemem zakázek 176 mld. USD, pokračujícím růstem tržeb a rozšiřováním marží a významnou tvorbou volného hotovostního toku nabírá GE Vernova na síle a zvyšujeme náš finanční výhled na rok 2026," uvedl generální ředitel Scott Strazik. „Nyní očekáváme, že do konce roku 2026 budeme mít nasmlouváno nejméně 125 GW plynových zařízení. Abychom této poptávce vyhověli, zůstáváme na dobré cestě dodat 20 GW roční produkce plynových turbín ve třetím kvartále roku 2026, s 24 GW v roce 2028, a zavádíme opatření k dosažení produkce 30 GW v roce 2030. Zaznamenáváme také pokračující růst poptávky v segmentu elektrifikace, kdy objednávky datových center dosáhly od začátku roku více než 5 miliard USD, což je více než dvojnásobek našeho celkového objemu za rok 2025. Jsem hrdý na to, s jakou disciplínou náš tým pracuje, a jsem přesvědčen, že nás čeká významná tvorba hodnoty," dodal Strazik.
Akcie GE Vernova Akcie GE Vernova (GEV) v předburzovní fázi obchodování oslabují o 6,40 % na 1 009,75 USD.
Akcie GE Vernova (GEV) před výsledky na 1 078,81 USD Ukazatel Ukazatel Kapitalizace (mld. USD) 287,3 P/E 49,3 Vývoj za letošní rok (%) +65,1 Očekávané P/E 49,7 52týdenní minimum (USD) 530,2 Prům. cílová cena (USD) 1218 52týdenní maximum (USD) 1195,94 Dividendový výnos (%) 0,2 Zdroj: GE Vernova, Bloomberg
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the OTTAVA™ Robotic Surgical System, the world's first table-integrated soft tissue robotic system. The system received marketing authorization for multiple procedures in general surgery, including Roux-en-Y gastric bypass, gastrectomy, cholecystectomy, splenectomy, gastric sleeve, small bowel resection, appendectomy, lysis of adhesio.
People gather next to a logo of Johnson & Johnson at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov Purchase Licensing Rights, opens new tab
CompaniesJuly 22 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Wednesday the U.S. Food and Drug Administration had granted marketing authorization for its robotic surgery device, clearing the way for the healthcare conglomerate to enter the soft-tissue robotic surgery market.
The Ottava robotic surgical system was authorized for use in multiple general surgery procedures in the upper abdomen, including gastric bypass, gastrectomy, gallbladder removal, gastric sleeve surgery, appendectomy and hiatal hernia repair.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
J&J said it would begin a U.S. commercial launch with select customers, while working to expand the system into additional indications and regulatory markets.
Reporting by Puyaan Singh in Bengaluru; Editing by Joyjeet Das
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Walt Disney (DIS 0.31%) shares have tumbled. They now trade 52% below their record from March 2021 as of July 20, at a price-to-earnings (P/E) ratio of 15.4. But the business is performing well from a fundamental perspective.
Netflix (NFLX +1.67%) has also faltered. Its shares are 50% off their peak from June 2025. However, they trade at a P/E ratio of 21.3, 38% more expensive than Disney.
Why is the House of Mouse so much cheaper than the streaming pioneer? This is the only answer that I can think of.
Image source: The Motley Fool.
Holding on to the past Investors who have followed Disney for a while know that the stock can never sustainably command a high valuation multiple from the investment community. That's particularly true right now. I believe there are two headwinds that pressure the stock.
The market probably continues to punish the stock because Disney's cable networks, a dying offering, are still a material part of the overall business. During fiscal 2025 (ended Sept. 27, 2025), this segment generated 10% of the company's total revenue and 17% of its operating income.
To be clear, these figures have continued to come down, but they highlight an anchor that prevents Disney from truly letting go of its past. This situation creates a financial impediment, as gains in other segments have to work harder to offset the secular decline of cable TV.
Another headwind relates to the nature of this company. Disney has always been a capital-intensive business. Creating and acquiring content is particularly expensive.
In the physical world, the theme parks and cruise ships require significant capital to maintain and grow. This reality isn't changing, and it sucks up capital that could be returned to shareholders in the form of higher dividends and stock buybacks.
Putting a premium on a pure-play streamer Netflix shares don't look like their usual self these days. They're 50% below their all-time high. The stock immediately sank after the business reported its first-quarter results in April. And it fell again when Netflix gave investors its latest update on July 16.
Slower growth might be one of the main reasons for the dip. Netflix is forecasting a 13.3% year-over-year revenue gain in 2026. That would be the third slowest increase in the past 10 years.
Even during a notable share-price decline, though, Netflix stock commands a 38% premium to Disney. The market clearly highly values a pure-play streaming entity, especially one that pioneered the industry and has long held such a dominant position. Netflix doesn't have legacy assets that are a drag on its financial performance. It has been able to focus fully on streaming entertainment, with a natural evolution into advertising and live events.
Over the past five years, Netflix's revenue increased by 73%, higher than Disney's 62% gain. In the most recent fiscal quarter, the former posted a stellar operating margin of 33.4%, well ahead of the latter's 18.3%. These important financial metrics support the market's more favorable view of Netflix.
Today's Change
(
-0.31
%) $
-0.30
Current Price
$
96.11
Where the opportunity is Investors might be inclined to move quickly to buy Netflix shares while they've fallen so much. But I don't believe this is the right opportunity. Even at a P/E multiple of 21.3, the stock isn't cheap, particularly when competitive forces are creating the most difficult operating environment in the company's history.
Disney looks like the better buy of these two entertainment juggernauts. Its valuation, of course, presents an attractive opportunity for long-term investors to acquire a competitively advantaged company. Consensus analyst estimates call for adjusted diluted earnings per share annualized growth of 11.5% between fiscal 2025 and fiscal 2028, as success in streaming and experiences drive higher profits going forward.
It doesn't look as if Netflix's premium is going away anytime soon. However, Disney's discount is too hard to pass up.
Target is making back-to-school and back-to-college shopping more affordable for busy families with lower prices on thousands of items and 95% of school supply deals at or below last year's prices
Guests can save up to 30% on stylish school and college favorites from July 26-Aug. 1, then enjoy fun in-store back-to-school and back-to-college events later in August
, /PRNewswire/ -- Target Corporation (NYSE: TGT) is bringing together the style and value students and families are looking for this back-to-school and back-to-college season. From a weeklong savings event on stylish school-year finds to expanded in-store experiences and reduced prices on thousands of items — including 95% of school supply deals priced at or below last year's retail prices — Target is making it easier for guests to get ready for the school year in style. Together, these efforts reinforce Target's merchandising authority as the destination where guests discover trend-forward style at incredible value.
"From picking out a first-day outfit to finding the perfect sheets for your dorm, back-to-school and college is filled with so many meaningful moments, and Target is making them easier for busy families," said Cara Sylvester, executive vice president and chief merchandising officer, Target. "With fresh styles, everyday essentials and incredible value all in one place, we're helping families spend less time shopping and more time celebrating the start of a new school year."
Style-forward savings
From July 26 through Aug. 1, Target's weeklong back-to-school savings event gives guests even more ways to save on stylish finds they'll use throughout the school year.
Highlights include:
Save up to 30% on kids' clothing 25% off kids' shoes 30% off uniform polos and dresses 20% off Champion backpacks and lunch items 20% off All in Motion backpacks, lunch kits and hydration 30% off teen home decor Affordable style all season long
To help families save on everything they need for the school year, Target has reduced prices on thousands of items across school supplies and everyday essentials, including many in food and beverage. Nearly all school supply prices are at or below last year's retail prices, and guests can stock up on school supplies starting at 25¢ and apparel from $5. College students will also find dorm room storage, decor and bathroom essentials starting at $5, along with hundreds of stylish college essentials under $20.
Guests can save even more throughout the season with additional ways to shop:
Tax-free weekends: Target will participate in all state sales-tax holidays where applicable. Target Circle offers: College students and teachers can save 20% off one storewide purchase with Target Circle during the promotional period.1 Where guest experience, style and value come together
On Aug. 8, Target will host back-to-school events in 2,000 stores, expanding from 400 locations last year, to create a more engaging shopping experience where students and families can discover affordable style, personalize school-year essentials and enjoy giveaways. Guests can explore new arrivals from Cat & Jack and receive take-home personalization kits with custom bag tags and puffy stickers, while nearly 800 stores will feature new Heyday headphone colorways with sticker sheets and rhinestone decals to customize tech accessories.
On Aug. 16, Target will expand its back-to-college move-in events to nearly 150 stores this year, creating welcoming shopping experiences that help students discover stylish dorm and everyday essentials at affordable prices during peak move-in season. Twenty flagship locations will feature elevated front-of-store experiences with DJs, mascots, product sampling and giveaway bags, while 120 additional stores will host welcome events with giveaway bags and samples timed to local campus move-in dates.
1Subject to terms and conditions. Valid July 5, 2026, through Sept. 12, 2026. College student or teacher verification required.
About Target
Target Corporation (NYSE: TGT) brings together style, design and value to offer a distinct assortment and elevated shopping experience across more than 2,000 U.S. stores and online. Powered by more than 400,000 team members, Target serves millions of families each week and invests in the communities where they live and work to support growth and opportunity for all.
Joe DePinto will join Target's Board of Directors on Aug. 1 and serve on Infrastructure & Finance and Audit & Risk committees.
DePinto adds expertise in operations, loyalty, fresh food and omnichannel capabilities as the company charts its next chapter of growth under CEO Michael Fiddelke. , /PRNewswire/ -- Target Corporation (NYSE: TGT) announced the election of Joe DePinto, former president and chief executive officer of 7-Eleven, Inc., to its Board of Directors. The appointment is another step Target is taking to accelerate its enterprise strategy and fuel new growth under CEO Michael Fiddelke.
"At Target, we're leading with merchandising authority, elevating the guest experience, accelerating technology and strengthening our team and communities to pave a new path of growth," said Fiddelke. "Joe has spent his career relentlessly focused on the customer, empowering teams and delivering operational excellence. His perspective and experience in retail, with a particular emphasis in food and digital commerce, will be a tremendous asset to our Board as we continue building momentum against our strategy."
DePinto brings more than three decades of leadership experience across retail and consumer products, having led the world's largest convenience retailer through significant expansion, digital innovation and evolving consumer preferences. During his tenure, 7-Eleven, Inc. accelerated investments in omnichannel capabilities, loyalty programs and fresh food offerings while growing its store footprint and strengthening its position as a leading convenience retailer.
DePinto has also held leadership roles at PepsiCo and GameStop and brings public company governance expertise from boards including Brinker International, Jo-Ann Stores and OfficeMax.
"We're continually focused on ensuring the Board brings together the expertise and perspectives that align with the company's strategic priorities," added Christine Leahy, Lead Independent Director of Target's Board of Directors. "Joe's extensive experience leading growth and omnichannel innovation across retail and consumer businesses will be a valuable addition to our Board as we help guide Target's long-term success."
About Target
Target Corporation (NYSE: TGT) brings together style, design and value to offer a distinct assortment and elevated shopping experience across more than 2,000 U.S. stores and online. Powered by more than 400,000 team members, Target serves millions of families each week and invests in the communities where they live and work to support growth and opportunity for all.
A Target logo appears in this illustration taken August 18, 2025. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab
CompaniesJuly 22 (Reuters) - Target (TGT.N), opens new tab on Wednesday named former 7-Eleven CEO Joe DePinto to its board, adding an industry veteran as the retailer works to sustain a turnaround under new CEO Michael Fiddelke.
DePinto, who led convenience-store operator 7-Eleven for nearly two decades, brings over 30 years of experience across the retail and consumer sectors. He has also held senior leadership roles at PepsiCo (PEP.O), opens new tab and GameStop (GME.N), opens new tab.
Get a daily digest of breaking business news straight to your inbox with the Reuters Business newsletter. Sign up here.
The appointment comes as Target seeks to regain momentum after several years of sluggish sales growth, which saw shoppers gravitate toward lower-priced rivals and pull back on discretionary purchases.
Since taking over as CEO earlier this year from longtime chief Brian Cornell, Fiddelke has focused on improving inventory availability, strengthening product assortment and sharpening the retailer's value proposition.
The company has been lowering prices and releasing fresher products on the shelves to compete with aggressive pricing strategies of rivals such as Walmart (WMT.O), opens new tab and Amazon (AMZN.O), opens new tab.
The efforts have shown early signs of success. In May, Target raised its annual sales-growth forecast for the first time in two years after posting stronger-than-expected quarterly results.
It, however, cautioned that a tough macroeconomic backdrop could continue to pressure demand.
DePinto's appointment also follows a shareholder vote last month rejecting a proposal that would have required the board's chair to be an independent director. The measure was prompted by Target's decision last year to move Cornell into the role of executive chair.
The retailer said DePinto will join its board on August 1 and serve on infrastructure and finance, and audit and risk committees.
Reporting by Koyena Das in Bengaluru; Editing by Maju Samuel
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Provides a state-of-the-art overview of the evidence on the critical role of bradykinin B2 receptor in the pathogenesis of bradykinin-mediated angioedemaExplains the scientific foundation for targeting the bradykinin B2 receptor as a therapeutic strategy for additional bradykinin-mediated diseases ZUG, Switzerland, July 22, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced the publication of a comprehensive review article in Clinical Reviews in Allergy & Immunology providing a state-of-the-art overview of the biology of bradykinin and the bradykinin B2 receptor (B2R), and summarizing the growing body of evidence supporting B2R antagonism as a therapeutic strategy for bradykinin-mediated diseases. Drawing on decades of scientific and clinical research, the article traces the evolution of bradykinin B2 receptor antagonism from foundational discoveries in kinin biology to a clinically validated therapeutic approach.
"The long history of scientific and clinical evidence demonstrates that bradykinin B2 receptor antagonism is a validated and foundational therapeutic approach in the management of bradykinin-mediated angioedema," said Anne Lesage, Ph.D., Chief Early Development Officer of Pharvaris. "A deep understanding of kinin biology and of the roles of bradykinin and the bradykinin B2 receptor in allergic and immunological conditions, such as bronchial asthma, chronic cough, allergic rhinitis, and chronic urticaria, can inform the development of novel therapeutic interventions. Bradykinin B2 receptor antagonism may be a potential viable therapeutic strategy for various diseases; to date, there have been no observations of increased risks of long-term unfavorable effects from the antagonism of the bradykinin B2 receptor. Rooted in scientific expertise, Pharvaris is proud to contribute to the growing knowledge of the roles of bradykinin in the pathogenesis of bradykinin-mediated diseases and of the potential for the antagonism of bradykinin B2 receptor as therapeutic strategy in managing these conditions.”
Advances in understanding kinin biology have enabled the development of mechanism-based treatment approaches. By directly blocking the receptor through which bradykinin exerts its pathological effects, bradykinin B2 receptor antagonists target the main mediator of swelling regardless of the upstream mechanism driving excess bradykinin production and/or bradykinin B2 receptor activity. Clinical experience has supported the therapeutic relevance of this approach and has contributed to a deeper understanding of the role of bradykinin signaling across multiple disease states.
In addition to its established role in HAE, including HAE with normal C1 inhibitor, and AAE-C1INH, growing evidence suggests that bradykinin signaling may contribute to a broader range of immunological and inflammatory disorders, underscoring the potential importance of continued research into bradykinin B2 receptor-targeted therapies.
The full article can be found here: Therapeutic Targeting of the Bradykinin B2 Receptor in Immunological and Vascular Diseases: Insights from Kinin Biology to Clinical Outcomes
About Pharvaris
Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs in bradykinin-mediated conditions, including all types of bradykinin-mediated angioedema. Pharvaris’ aspiration is to offer therapies with injectable-like efficacy™, a well-tolerated profile, and the convenience of oral administration to prevent and treat bradykinin-mediated angioedema attacks. By delivering on this aspiration, Pharvaris aims to provide a new standard of care in bradykinin-mediated angioedema. For more information, visit https://pharvaris.com/.
Forward Looking Statements
This press release contains certain forward-looking statements that involve substantial risks and uncertainties. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements relating to our future plans, studies and trials, and any statements containing the words “believe,” “anticipate,” “expect,” “hope,” “estimate,” “may,” “could,” “should,” “would,” “will,” “intend” and similar expressions. These forward-looking statements are based on management’s current expectations, are neither promises nor guarantees, and involve known and unknown risks, uncertainties and other important factors that may cause Pharvaris’ actual results, performance or achievements to be materially different from its expectations expressed or implied by the forward-looking statements. Such risks include but are not limited to the following: uncertainty in the outcome of our interactions with regulatory authorities, including the FDA; the expected timing, progress, or success of our clinical development programs, especially for deucrictibant immediate-release capsules and deucrictibant extended-release tablets, which are in late-stage global clinical trials; our ability to replicate the efficacy and safety demonstrated in the RAPIDe-1, RAPIDe-2, RAPIDe-3, and CHAPTER-1 Phase 2 and Phase 3 studies in ongoing and future nonclinical studies and clinical trials, such as CHAPTER-3, and CREAATE; the outcome of regulatory approvals, including the outcome of our NDA for the on-demand treatment of acute attacks of HAE; risks arising from epidemic diseases, which may adversely impact our business, nonclinical studies, and clinical trials; our ability to potentially use deucrictibant for alternative purposes, for example to treat C1-INH deficiency (AAE-C1INH); the value of our ordinary shares; the timing, costs and other limitations involved in obtaining regulatory approval for our product candidates, or any other product candidate that we may develop in the future; our ability to establish commercial capabilities or enter into agreements with third parties to market, sell, and distribute our product candidates; our ability to compete in the pharmaceutical industry, including with respect to existing therapies, emerging potentially competitive therapies and with competitive generic products; our ability to market, commercialize and achieve market acceptance for our product candidates; our ability to produce sufficient amounts of drug product candidates for commercialization; our ability to raise capital when needed and on acceptable terms; regulatory developments in the United States, the European Union and other jurisdictions; our ability to protect our intellectual property and know-how and operate our business without infringing the intellectual property rights or regulatory exclusivity of others; our ability to manage negative consequences from changes in applicable laws and regulations, including tax laws (including the Biosecure Act), our ability to maintain an effective system of internal control over financial reporting; changes and uncertainty in general market conditions; disruptions at the FDA and other agencies; changes and uncertainty in general market, political and economic conditions, including as a result of inflation and geopolitical conflicts; changes in regulations and customs, tariffs and trade barriers; and the other factors described under the headings “Cautionary Statement Regarding Forward-Looking Statements” and “Item 3. Key Information—D. Risk Factors” in our Annual Report on Form 20-F and other periodic filings with the U.S. Securities and Exchange Commission. These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. While Pharvaris may elect to update such forward-looking statements at some point in the future, Pharvaris disclaims any obligation to do so, even if subsequent events cause its views to change. These forward-looking statements should not be relied upon as representing Pharvaris’ views as of any date subsequent to the date of this press release.
Contact
Maggie Beller
Vice President, Head of Corporate and Investor Communications [email protected]
Since its founding in December 1998, PayPal NASDAQ: PYPL has grown alongside e-commerce into a financial services giant. Today, the company’s market cap exceeds $50 billion. But along the way, the stock has not been kind to investors.
Following its return to public trading in July 2015 after being spun off from eBay NASDAQ: EBAY, PayPal surged to its all-time high of $308.53 per share in July 2021. But it has been a difficult ride for shareholders, with PYPL down nearly 82% since then.
Get PayPal alerts:
PayPal Holdings, Inc. (PYPL) Price Chart for Wednesday, July, 22, 2026
But last week, long-term holders were treated to an unexpected catalyst: Stripe and private equity firm Advent International proposed a joint $53.4 billion acquisition of PayPal. Shares rose up as much as 19% in pre-market trading on July 15, finishing the day up nearly 16%.
In the days that followed, PayPal’s board declined the offer, stating that the bid was too low. Nonetheless, a deal could still materialize.
In the meantime, shares have continued to climb above their pre-bid level. Here’s what investors need to know about the digital payment platform’s future, and whether or not the stock’s recent turnaround can be sustained.
Details of the $53 Billion Bid PayPal Passed OnPayPal Today
$55.85 -0.97 (-1.71%)
As of 07/21/2026 04:00 PM Eastern
52-Week Range$38.46▼
$79.50Dividend Yield1.00%
P/E Ratio10.48
Price Target$54.61
Seeing a potentially mispriced company, the offer was priced at $60.50 per share—about 6.5% higher than the stock's July 20 closing price, and around 28% above its July 14 pre-announceemnt close.
Had the bid been accepted, at $53.4 billion, it would have been the largest fintech acquisition in history. Stripe and Advent reportedly planned to hold equal ownership stakes in PayPal rather than divide the company’s assets.
The move makes sense for privately-held Stripe, a financial infrastructure platform that provides global payment processing, subscription management, and fraud prevention services to businesses.
But that offer was not aimed at absorbing PayPal’s 439 million active consumer and merchant accounts around the world. According to Tech Times, the bid was aimed at securing PayPal’s “consumer-facing stablecoin distribution network and the peer-to-peer trust relationship those accounts represent.
PayPal’s Stablecoin Is the Ultimate PrizeLaunched on Aug. 7, 2023, PayPal’s native stablecoin—PayPal USD (PYUSD)—represents the next chapter in the company’s payment facilitation playbook.
Built on the Ethereum (ETH) and Solana (SOL) blockchains ,PYUSD is designed to remain worth $1 and is backed by cash and short-term U.S. government debt. Eligible PayPal users can currently earn a variable 4% annual reward by holding it in their accounts.
But more importantly, Visa NYSE: V added PYUSD to its stablecoin settlement platform, allowing participating issuers and acquirers to use the token for certain settlement transactions across Visa’s network. The integration could expand PYUSD’s role in cross-border and on-chain payments as Visa builds out its stablecoin infrastructure.
Visa Today
V
Visa
$355.94 -4.63 (-1.28%)
As of 07/21/2026 03:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range$293.89▼
$365.14Dividend Yield0.75%
P/E Ratio31.00
Price Target$398.36
According to Visa’s 2025 annual report, the company reported 4.7 billion Visa-branded cards with total volume of $16.7 trillion last year.
Meanwhile, industry consultancy firm Grand View Research forecasts the global stablecoins segment of the decentralized finance market to grow to nearly $183 billion by 2033 from $3.3 billion in 2025—good for an almost comical compound annual growth rate of 69%.
As part of its expanded payment settlement rails, Visa’s decision to embrace the PYUSD stablecoin to allow partners to settle fiat currency-backed transactions directly on-chain is poised to be a massive windfall for PayPal.
At the same time, PayPal continues to expand PYUSD’s utility as a low-cost, near-instant payment and transfer mechanism within its digital wallet ecosystem on Venmo and PayPal.
Together with the $60.50 offering, this suggests that at current prices, shares of the San Jose, California-based firm could be dramatically undervalued.
Current Price$55.85High Forecast$100.00Average Forecast$54.61Low Forecast$32.00PayPal Stock Forecast Details
For now, Wall Street has yet to price in the stablecoin story.
Based on the 46 analysts who cover the stock, PayPal carries a consensus Hold rating and an average 12-month price target implies nearly 2% downside from current prices.
While that may be discounting the underlying price drivers PayPal is set to enjoy, it also overlooks solid fundamentals and sound management.
In Q1, revenue growth stood at 7.21%—a dramatic year-over-year increase from 1.2% in Q1 2025.
Similarly, after four consecutive quarters of free cash flow (FCF) contraction, PayPal posted back-to-back quarters of FCF in Q4 2025 and Q1 at nearly 354% and 155%, respectively.
Earnings per share (EPS) offers another clue. Despite their struggles, PayPal has beat on earnings in nine of the last 11 quarters, including seven of the last eight. In Q1, the company reported EPS of $1.34, topping the consensus estimate of $1.27, and with a trailing price-to-earnings ratio of 10.66, PayPal’s earnings are expected to grow 8.27% in the next year.
In the company's Q1 earnings call, PayPal’s new CEO Enrique Lores, who officially took on that role on March 1, reaffirmed the company’s focus on three lines of business: Checkout/PayPal, Consumer Financial Services/Venmo, and Payment Services/Crypto—the latter of which underscores the significance of PYUSD.
Management also expects at least $1.5 billion of gross run-rate savings over the next two to three years as broad AI and automation adoption drives down operating costs. Ultimately, these factors should continue to fuel a long-awaited rebound for the company, which next reports earnings on July 28.
Should You Invest $1,000 in PayPal Right Now?Before you consider PayPal, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PayPal wasn't on the list.
While PayPal currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Intel's results on Thursday will show whether the American chip icon has the numbers to back a Wall Street rally that has sent its shares nearly three times higher this year, as its turnaround push wins over investors and the AI buildout powers demand.
Intel stock NASDAQ:INTC heads into Thursday’s earnings with expectations running ahead of a turnaround story.
Shares remain up more than 160% this year despite falling over 30% from June’s high, as investors bet that AI-server demand can revive the company’s processor business and support its manufacturing ambitions.
Wall Street expects second-quarter revenue of about $14.44 billion and adjusted earnings of 22 cents a share, slightly above Intel’s guidance for $13.8 billion to $14.8 billion and 20 cents.
Intel reports after Thursday’s close, followed by a 5 pm ET call. Options traders are pricing a 13.52% move in either direction.
The strongest part of Intel’s comeback is its Data Center and AI division.
First-quarter revenue rose 22% to $5.1 billion, driven largely by a 27% increase in server processor prices, even as unit volumes fell 5% and supply constraints prevented Intel from meeting all demand.
That mix explains why analysts broadly expect a beat.
Wedbush analyst Matt Bryson said the question was “not whether Intel beats expectations, but rather how does sentiment shift,” according to TipRanks.
He estimates data-centre sales could rise about 10% sequentially and 40% year on year, with double-digit server price increases accounting for much of the growth.
The difficulty is that strong pricing is already embedded in expectations.
Investors will want evidence that volumes are also improving and that constrained production is easing. Intel’s 39% adjusted gross-margin forecast, below the 41% reported in the first quarter, makes the quality of any beat especially important.
Foundry economics remain the fault lineIntel Foundry reported $5.42 billion of first-quarter segment revenue, but only $174 million came from external customers.
The unit recorded a $2.44 billion operating loss, showing that most reported sales still reflect manufacturing work for Intel’s own product divisions rather than a mature third-party business.
KeyBanc analyst John Vinh has taken the bullish view.
He raised his price target to $155 from $110 and kept a Buy rating, after estimating that Intel 18A yields had improved to about 85% from 65% in the previous quarter.
His supply-chain checks also indicated that 14A remains on course for mass production in the second half of 2028.
Intel’s new collaboration with Fortinet offers another proof point. The companies will jointly develop Fortinet’s SP6 security processor using Intel’s design, packaging and manufacturing capabilities.
However, neither financial terms nor a production timetable were disclosed, so the agreement does not yet establish that foundry returns are improving.
Third-quarter guidance must show that stronger processor demand can lift margins while Intel continues funding factories and advanced process development.
UBS raised its target to $121 from $83 while retaining a Neutral stance, citing data-centre demand and possible pricing gains.
The firm said investors would also require updates on manufacturing execution and external foundry customers.
Intel’s planned job reductions within its data-centre group could support expenses, but they underline how aggressively management is still reshaping the business.
The bullish outcome combines faster data-centre growth, margins above guidance, improving 18A economics and firmer external commitments.
The bearish outcome is a server-led beat accompanied by weak margins, supply constraints or continued ambiguity around foundry profitability.
, /PRNewswire/ -- American Express and ALL Accor, Accor's booking platform and loyalty program, today announced a new global partnership rolling out beginning in 2026 across 12 locations, introducing elite status matching and a new Membership Rewards® points transfer option for eligible Card Members.
ALL Accor & Amex partnership Launching in phases across Australia, Austria, Canada, France, Germany, Hong Kong, Italy, Japan, Mexico, Singapore, the United Kingdom and New Zealand, the partnership is designed to elevate the travel journey, from booking and planning to on-property recognition and rewards, across Accor's portfolio of more than 45 brands worldwide, including Raffles, Fairmont and Sofitel.
"This collaboration reflects our continued focus on delivering premium travel value and meaningful rewards for our Card Members," said Suzanne Morel, Senior Vice President, International Products and Partnerships at American Express. "Together with Accor, we're amplifying the value of two trusted global brands, by pairing meaningful recognition with greater redemption flexibility, to deliver elevated, end-to-end experiences for Card Members across markets."
"Bringing the ALL Accor promise to life in new ways, we're connecting our global hospitality ecosystem with American Express Card Members around the world," said Mehdi Hemici, Chief Loyalty & E-Commerce Officer at Accor. "American Express' premium Membership base is perfectly suited for our luxury portfolio. By combining our expansive brands and experiences with the strength of their global reach, we're creating more seamless, personalized stays and unlocking richer ways for guests to engage with ALL Accor at every stage of their journey."
Anchored by elite status matching into ALL Accor and complemented by a new Membership Rewards® points transfer option to ALL Accor, the partnership expands the power and value of American Express Membership.
Elite Status Match for Eligible Card Members
Eligible American Express Card Members will be able to match their American Express status to an equivalent tier within ALL Accor, unlocking enhanced travel benefits and meaningful on-property recognition when staying at participating Accor properties around the world, including:
American Express Consumer, SBS and Corporate Platinum® Card Members will be eligible to receive ALL Accor Gold status which includes free Wi-Fi, welcome amenities, late check-out, complimentary room upgrades (subject to availability) and bonus ALL Accor points. Membership Rewards® Points Transfer
The partnership expands the flexibility and value of American Express Membership Rewards®, giving eligible Card Members a new option to transfer points to the ALL Accor loyalty program. Point conversion ratios will vary by location.
Transferred points may be redeemed within the ALL Accor program across its vast global hotel network of 45 hotel brands, dining, experiences, and more than 110 partners, in accordance with ALL Accor program terms and conditions.
Further country specific details will be made available throughout the year.
ABOUT AMERICAN EXPRESS
American Express (NYSE: AXP) is a global payments and premium lifestyle brand powered by technology. Our colleagues around the world back our customers with differentiated products, services, and experiences that enrich lives and build business success.
Founded in 1850 and headquartered in New York, American Express' brand is built on trust, security, service, and a rich history of delivering innovation and Membership value for our customers. We seek to provide the world's best customer experience every day to a broad range of consumers, small and medium-sized businesses, and large corporations, and we build and manage relationships with millions of merchants across our global network.
For more information about American Express, visit americanexpress.com, americanexpress.com/en-us/newsroom/, and ir.americanexpress.com.
ABOUT ALL ACCOR
ALL Accor is a booking platform and loyalty programme embodying the Accor promise during and beyond the hotel stay. Through the ALL.com website and app, customers can access an unrivalled choice of stays from more than 45 Accor brands in 110 countries, always at the best price. The ALL Accor loyalty programme gives members access to a wide range of rewards, services and experiences, along with over 100 renowned partners. ALL Accor supports its members daily, enabling them to live their passions with over 7,000 events worldwide each year: local activities, chef masterclasses, major sports tournaments and the most eagerly awaited concerts. ALL Accor is the loyalty programme preferred by travellers.
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into International Business Machines Corporation (NYSE:IBM) for potential securities fraud after its significant stock drop.
If you invested in IBM, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ibm-class-action-lawsuit.
Key Details of the IBM ($IBM) Class Action Investigation:
Investigation Overview: Securities fraud relating to IBM’s misrepresentations about the pace of securing new business deals and the strength of its IBM Z product outlook Stock Decline: July 14, 2026 – 25% Stock DropAction: Contact BFA Law to discuss your rights
Why is IBM Being Investigated for Securities Fraud?
IBM is being investigated for securities fraud following a significant stock drop. The decline in IBM’s stock price caused significant losses to investors.
IBM is a global technology and consulting company that focuses on hybrid cloud and artificial intelligence. IBM uses IBM Z to deliver enhanced AI acceleration through multi-model AI capabilities, low unit cost architecture at scale for workloads that require end-to-end encryption, continued availability, and ultra-high throughput.
BFA is investigating whether IBM misled investors about its pace securing new business deals and the strength of its IBM Z outlook.
Why did IBM’s Stock Drop?
On July 14, 2026, IBM released its 2026 Q2 financial results. IBM announced a disappointing quarter that it attributed to “a shortfall in our Z performance and the associated software stack, primarily in Transaction Processing.” IBM also revealed that it had “faltered,” and “did not adapt and move quickly enough” so that “numerous large deals failed to close on the timelines we expected, driving the majority of our shortfall.”
This news caused the price of IBM stock to decline over $75 in intraday trading on July 14, 2026, or over 25%.
Click here for more information: https://www.bfalaw.com/cases/ibm-class-action-lawsuit.
What Can You Do?
If you invested in IBM, you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.
Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”
Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating Barry Diller’s bid to buy MGM Resorts International (NYSE:MGM). MGM is incorporated in Delaware.
Barry Diller is a member of MGM’s board of directors. People, Inc. (“People,” f/k/a/ IAC, Inc.), a company that Diller founded and controls, is MGM’s largest single stockholder. On June 1, 2026, People made an unsolicited bid to buy the remaining MGM stock for $48.30 per share.
If you are a current shareholder of MGM, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/mgm-resorts-investigation.
Key Details of the MGM ($MGM) Investigation:
Investigation Overview: Breaches of Fiduciary Duty in connection with Barry Diller’s offer to acquire the remaining stock of MGM for $48.30 per shareAction: Contact BFA Law to discuss your rights Why is the MGM Transaction being Investigated?
As a director, Diller owes fiduciary duties to MGM and its stockholders. People also recently entered a governance agreement with MGM that gave People the right to designate two MGM directors going forward. Because Diller “stands on both sides” of the proposed deal, and because other MGM fiduciaries could potentially receive benefits that other stockholders do not receive, these facts create a create conflicts of interest under Delaware law. If MGM and Diller reach an agreement, they must comply with Delaware’s strict requirements for “cleansing” these conflicts and ensuring the deal is fair to MGM’s stockholders.
In a news release on June 1, MGM stated that the board of directors “will carefully review and consider the proposal to determine the course of action that it believes is in the best interests of the Company and all of its shareholders.”
BFA is investigating whether the potential agreement complies with Delaware law.
If you are a current holder of MGM stock, you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.
Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”
Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Past performance is not an indicator of future performance. This post is illustrative and educational and is not a specific offer of products or services or financial advice. Information in this article is not an offer to buy or sell or a solicitation of any offer to buy or sell the securities mentioned herein. Information presented is believed to be factual and up-to-date, but we do not guarantee its accuracy, and it should not be regarded as a complete analysis of the subjects discussed. Expressions of opinion reflect the judgment of the authors as of the date of publication and are subject to change.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Morgan Stanley analyst Adam Wood cut Salesforce (NYSE:CRM | CRM Price Prediction) price target by 35% on July 21, 2026, Morgan Stanley analyst Adam Wood downgradedfrom Overweight to Equal Weight and slashed his Salesforce price target from $287 to $185, a reduction of roughly 35%. CRM stock fell as much as 3.9% intraday and closed at $170.06, down about 2.2% on a day the NASDAQ Composite rallied around 1.4%. It was the second ratings downgrade for Salesforce this month.
Ticker Company Firm Action Old Rating New Rating Old Target New Target CRM Salesforce Morgan Stanley Downgrade & PT Cut Overweight Equal Weight $287 $185 A Call About Timing, With the AI Thesis Intact The key nuance: Wood is bullish on the leading indicators for Agentforce, Salesforce’s agentic AI platform, and its adoption trajectory. His concern is timing and scale.
The disconnect is real. Agentforce momentum exists, but it has not yet shown up where it matters most for the stock: current remaining performance obligations, or cRPO, a key forward indicator of future subscription revenue. cRPO has stayed weak, signaling company-wide growth has not yet inflected.
The Scale Problem, in Numbers Agentforce generated a $3.4 billion annualized revenue run rate last quarter. Against roughly $46 billion in total company revenue projected for the fiscal year, Agentforce is still only about 7% of the business, not yet large enough to offset drag from weaker legacy segments, specifically Commerce and Tableau.
Wood still thinks Salesforce could emerge as an AI winner. He believes the inflection to company-wide organic growth will take longer than expected, and his lower target reflects compressed valuation multiples across the software sector. Salesforce continues pushing deeper into agents: in June 2026 it acquired Fin, a customer-service AI agent company built on an outcome-based pricing model and running on its own custom AI model, independent of the major AI labs.
SoFi Active Invest is offering a limited-time promotion. Open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts. See for yourself by clicking here now.
The Bargain Counterargument At around $168 to $174, Salesforce shares trade below Wood’s new $185 target, at roughly 12 times this year’s earnings estimates. Some investors read that as pricing in almost no growth. If the agentic AI transition delivers, the stock could look cheap in hindsight. Salesforce is also returning significant cash to shareholders through buybacks, a support beneath the price while the market waits.
The 2026 Backdrop The downgrade lands in a rough year for CRM stock. Salesforce is down about 35% year to date, a slide driven less by any single quarter and more by broad multiple compression across software. Investors face a hard question: will AI coding and agent tools disrupt traditional SaaS business models, or supercharge them? Until that resolves, Salesforce trades under uncertainty.
Wood’s note underscores the real issue. The bull and bear cases hinge on the same variable: how fast AI revenue scales to outrun legacy weakness. Wood thinks it takes longer than the market hoped, so he moved to the sidelines. Whether that proves cautious or prescient depends on numbers Salesforce has not yet delivered.
Want Up To $1,000? SoFi Is Giving New Active Invest Users Free StockLooking to grow your money but unsure where to begin? SoFi Active Invest is offering a limited-time promotion—open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts.
From $0 commission trading to fractional shares and automated investing, this app is designed to simplify investing for everyone, whether you’re just starting or already experienced. Its easy to sign up and secure your bonus.
WOKING, England--(BUSINESS WIRE)--Linde (Nasdaq: LIN) has been included in the FTSE4Good Index Series for the 11th consecutive year, recognizing its continued leadership in sustainable business practices. “Sustainability is embedded in how we operate—from driving continuous improvement across our operations while supporting our customers' decarbonization goals to robust governance and community engagement,” said Erin Catapano, Vice President Sustainability, Linde. “Our continued inclusion in th.
, /PRNewswire/ -- GoldMining Inc. (TSX: GOLD) (NYSE American: GLDG) (the "Company" or "GoldMining") is pleased to announce that it has filed a technical report (the "Technical Report") which includes the previously announced preliminary economic assessment (the "PEA"), in respect of its São Jorge Project (the "Project"), located in Pará State, Brazil.
The Technical Report, titled "NI 43-101 Technical Report and Preliminary Economic Assessment for the São Jorge Gold Project, Pará State, Brazil" with an effective date of June 9, 2026, is available under the Company's respective profiles at www.sedarplus.ca and www.sec.gov. All currency amounts herein are in US dollars unless otherwise indicated.
The PEA is preliminary in nature, and there is no certainty that the reported results will be realized. The PEA includes inferred mineral resources, which are considered too speculative geologically to have the economic considerations applied to them that would enable them to be categorized as mineral reserves. There is no certainty that this PEA, including the conceptual economics set out therein, will be realized.
São Jorge PEA Highlights
Strong Economics & Upside Leverage: Modelled an after-tax net present value at a 5% discount rate ("NPV5%") of $532 million and an after-tax internal rate of return ("IRR") of 42.4% utilizing base case gold price of $3,500 per ounce ("oz"). At a gold price of $4,400/oz, the modelled after-tax NPV5% increases to $836.8 million, yielding an IRR of 58.6% and an initial payback of just 2.4 years. High Capital Efficiency & Infrastructure Advantage: Initial capital is estimated at a highly manageable $202 million (including a 25% contingency), representing an attractive 2.6x base case NPV5% to initial capital ratio. This relatively low capital hurdle is directly supported by the Project's ideal location, situated adjacent to existing power lines, paved highways, and an available skilled workforce. Steady Production & Cash Flow: The PEA envisages a robust internal free cash flow, supported by a stable gold production profile averaging an estimated 51,250 oz annually over a 10.6-year life of mine ("LOM"), with peak gold production of 57,200 oz per year in years 2 through 4. Conventional, Resilient Operation: The PEA contemplates a conventional open-pit truck-and-shovel operation and a processing rate of 5,500 tonnes per day. A proven processing flowsheet utilizing standard gravity and leach circuits achieves high metallurgical recoveries of 90% Au, supporting resilient margins and an estimated LOM All-In Sustaining Cost ("AISC") of $1,464/oz. Advancing Pre-Feasibility Studies: The Company is working to commence pre-feasibility studies as the Project is further de-risked and moves forward with permitting towards a construction decision. Alastair Still, CEO of GoldMining commented, "Filing the São Jorge Technical Report marks the next step in the advancement of our portfolio. We are excited by the Project's compelling proposition, which pairs a manageable initial capital requirement with steady gold production and a robust base case NPV set out in the PEA. In addition to offering significant exploration potential, the study highlights the asset's potential resilient margins and rapid payback profile. In parallel to advancing and de-risking the property as we commence prefeasibility studies, we remain focused on drilling nearby exploration targets within our prospective regional-scale property as we continue to unlock value across our broader multi-million ounce Americas portfolio"
For further information regarding the Project, including the PEA, please refer to the Technical Report.
Qualified Persons
Imola Götz, M.Sc. P.Eng., F.E.C., Vice President, Project Development of the Company and a Qualified Person, as such term is defined in NI 43-101, has supervised the preparation of this news release and has reviewed and approved the scientific and technical information contained herein.
About GoldMining Inc.
GoldMining Inc. is a public mineral exploration company focused on acquiring and developing gold assets in the Americas. Through its disciplined acquisition strategy, GoldMining now controls a diversified portfolio of resource-stage gold and gold-copper projects in Canada, the U.S.A., Brazil, Colombia, and Peru.
Notice to Readers
Disclosure regarding the Project, including the PEA, included herein, has been prepared by the Company in accordance with Canadian National Instrument 43-101 ("NI 43-101"). NI 43-101 is a rule developed by the Canadian Securities Administrators that establishes standards for public disclosure by issuer of scientific and technical information concerning mineral projects. NI 43-101 differs significantly from the disclosure requirements of the United States Securities and Exchange Commission ("SEC") generally applicable to U.S. companies subject to the SEC's disclosure requirements. Accordingly, information contained herein or in the Company's descriptions of its projects may not be comparable to similar information made public by U.S. companies reporting pursuant to SEC disclosure requirements.
Forward-Looking Statements
Certain of the information contained in this news release constitutes "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian and U.S. securities laws ("forward-looking statements"), which involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance and achievements to be materially different from the results, performance or achievements expressed or implied therein. Forward-looking statements, which are all statements other than statements of historical fact, include, but are not limited to the results of the PEA, the Company's plans and expectations regarding future opportunities and proposed work and future studies at the Project and the Company's other plans and expectations regarding the Project. Forward-looking statements are based on the then-current expectations, beliefs, assumptions, estimates and forecasts about the business and the markets in which GoldMining operates. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including: the inherent risks involved in the exploration and development of mineral properties, fluctuating metal prices, unanticipated costs and expenses, risks related to government and environmental regulation, social, permitting and licensing matters, and uncertainties relating to the availability and costs of financing needed in the future. These risks, as well as others, including those set forth in GoldMiningꞌs Annual Information Form for the year ended November 30, 2025, and other filings with Canadian securities regulators and the SEC, could cause actual results and events to vary significantly. Accordingly, readers should not place undue reliance on forward-looking statements. There can be no assurance that forward-looking statements, or the material factors or assumptions used to develop such forward-looking statements, will prove to be accurate. The Company does not undertake to update any forward-looking statements, except in accordance with applicable securities law.
TORONTO, Ontario — TheNewswire - July 22, 2026 — Renforth Resources Inc. (CSE: RFR | OTC: RFHRF | FSE: 9RR) ("Renforth" or the "Company") is pleased to update shareholders on our ongoing drill program on our wholly owned Victoria Ni/Cu/Co Open Pit Polymetallic deposit. The program has successfully completed two drillholes in the first undercut area, with visual mineralization encountered in both holes. First Undercut Area
BEIJING, July 22, 2026 /PRNewswire/ -- Baidu, Inc. ("Baidu" or the "Company") (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)), a leading AI company with strong Internet foundation, today provides an update on the Company's proposed voluntary conversion of its secondary listing status on The Main Board of The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange") to dual-primary listing (the "Primary Conversion"). Application for Conversion to Dual-Primary Listing.
GBP/USD remains steady after four days of losses, trading around 1.3370 during the European hours on Wednesday. The pair is holding a mildly bearish near‑term bias as spot remains capped beneath the 50‑day and nine-day Exponential Moving Averages (EMAs).
The 14-day Relative Strength Index (RSI) at 49.56 sits near the neutral line, hinting at consolidative momentum rather than a decisive directional push. Read more...
British Pound remains depressed against US Dollar following soft UK inflation dataThe British Pound (GBP) consolidates losses against the US Dollar (USD) on Wednesday, as a string of UK inflation figures provided some leeway for the Bank of England to maintain its “wait-and-see” stance through the coming months. The GBP/USD pair remains pinned near weekly lows, below 1.3400 following a nearly 1.2% decline in the last four days.
Data released by the UK National Statistics Office on Wednesday revealed that the Consumer Price Index (CPI) moderated to a 2.6% year-over-year (Y-o-Y) growth in June, from 2.8% in May, below the 2.7% forecasted by market analysts. The Core CPI, however, remained steady at 2.6% against expectations of a 2.5% reading. Read more...
British Pound attracts bids against Japanese Yen after mixed UK CPI dataThe British Pound (GBP) witnesses slight buying interest against its major currency peers after the release of the United Kingdom (UK) Consumer Price Index (CPI) data for June. Against the Japanese Yen (JPY), the British currency rebounds strongly from the intraday low of 218.20.
The Office for National Statistics (ONS) has reported a slower-than-expected headline CPI growth. The headline inflation arrives at 2.6% Year-on-Year (YoY), lower than the estimates of 2.7% and the previous reading of 2.8%. On a monthly basis, the headline inflation rises at a moderate pace of 0.1%, as expected, against the previous reading of 0.2%. Read more...
, /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Michael (Mike) Garrison has informed the company of his intent to retire after more than 20 years with BD, effective Oct. 2.
Garrison is currently executive vice president and president of the Medical Essentials and BioPharma Systems segments at BD. During his tenure, Garrison held several leadership roles including executive vice president and president of BD's Medical segment, worldwide president of Medication Management Solutions and worldwide president of Surgery. Prior to joining BD in 2005, Garrison held various roles across R&D and marketing within the MedTech industry.
"Mike has made a significant impact on BD over the past two decades, helping guide our company through periods of transformation while always keeping our customers, patients and associates at the center of his decisions," said Tom Polen, Chairman, CEO and President of BD. "He has built strong teams, developed exceptional leaders and helped position our business for the future. We are grateful for Mike's leadership, partnership and many contributions to BD, and we wish him well in his retirement."
Garrison will remain in his role through the end of the fiscal year. A comprehensive search is underway to identify the next president of Medical Essentials. Going forward, BioPharma Systems will report directly to Polen, streamlining the operating model and reflecting the segment's strategic importance as a growth driver.
"It has been a privilege to spend more than two decades at BD, working alongside talented teams who are deeply committed to improving healthcare around the world," Garrison said. "I will always value the people, purpose and impact that have made my time at BD so meaningful, and I look forward to seeing the company continue to advance the future of care."
About BD
BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X @BDandCo or Instagram @becton_dickinson.
Costco (COST 0.67%) shares hit their all-time high price of $1,094.32 in May. They have fallen 14% since then (as of July 20). Investors are hoping that the warehouse club operator can bounce back sooner rather than later.
Is $1,100 the next stop for this retail stock?
Image source: The Motley Fool.
The timing is unknown Shares would need to rise 17% to reach $1,100, which would establish a new record. Based on the stock's 126% trailing five-year return, this gain isn't out of the question. That's because this is a high-quality business with durable earnings growth.
The only unknown is timing. Shares could hit that price this year, next year, or after. No one has a clue.
Today's Change
(
-0.67
%) $
-6.27
Current Price
$
929.53
Investors shouldn't expect the stock to go straight up and to the right starting today. Shares can certainly fall in the near term. That's the volatile nature of the market.
The valuation is also a key variable to keep in mind. Costco stock is notoriously expensive. It trades at a price-to-earnings ratio of 47.2. This reveals the market's lofty expectations.
Investors should think twice about buying shares right now, as waiting for a sizable pullback is the best course of action. At the end of the day, it's worth remembering that this is a company with strong fundamentals that should at least be on your watch list.
Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Costco Wholesale. The Motley Fool has a disclosure policy.
NEW YORK--(BUSINESS WIRE)--Moody's Corporation (NYSE: MCO) today announced results for the second quarter 2026 and updated select metrics within its outlook for full year 2026. The Earnings Release and other earnings materials can be found on the Moody's IR website at ir.moodys.com. In addition, the Earnings Release will be furnished with the Securities and Exchange Commission (SEC) on a Form 8-K and will be available on the SEC website at www.sec.gov. Teleconference Details: Date and Time July.
Americká společnost OpenAI uvedla, že autonomní agent poháněný jejími pokročilými modely umělé inteligence (AI) se při bezpečnostním testu vymkl kontrole a způsobil narušení infrastruktury start-upu Hugging Face. Firma na svém blogu v úterý uvedla, že kvůli incidentu posílí své bezpečnostní mechanismy.
Firma v příspěvku uvedla, že testovala schopnosti některých svých nejpokročilejších modelů v kontrolovaném prostředí. Agentovi se však podařilo uniknout z omezení, dostat se na internet a proniknout do systému Hugging Face, aby se pokusil splnit cíl stanovený v rámci testu.
OpenAI označila tento únik za "bezprecedentní kybernetický incident zahrnující špičkové kybernetické schopnosti".
Hugging Face je platforma používaná k hostování velkých jazykových modelů s otevřeným kódem a datových sad. V komunitě kybernetické bezpečnosti vyvolala pozornost, když minulý týden na svém blogu oznámila, že se stala terčem kybernetického útoku, který byl "odlišný od všeho, co jsme dosud řešili", protože "jej od začátku až do konce řídil autonomní systém agentů AI".
Spoluzakladatel Hugging Face Clement Delangue v příspěvku na síti X napsal, že jeho společnost měla podezření, že útok mohl pocházet z některé z předních laboratoří AI, vzhledem ke schopnostem agenta. "A ukázalo se, že tomu tak bylo!“ napsal. "Je skutečně ohromující, že se to všechno odehrálo autonomně!" dodal.
Skutečnost, že OpenAI přiznala, že za narušením stály její pokročilé modely – přestože je umístila do prostředí, které označila za vysoce izolované – pravděpodobně zvýší obavy ohledně síly a rizik nejpokročilejších modelů umělé inteligence, uvedla agentura Reuters.
Kongresman Greg Casar z amerického státu Texas zvolený za Demokratickou stranu označil incident za znepokojivý. "Umělá inteligence se vyvíjí mimořádně rychle a neexistují žádné skutečné regulace, které by nás chránily,“ uvedl ve svém prohlášení. Zároveň vyzval k povinnému nezávislému testování bezpečnosti, povinnému zveřejňování bezpečnostních incidentů a mezinárodní spolupráci, která by "ochránila lidi před naprostou katastrofou".
Úřad národního ředitele pro kybernetickou bezpečnost, úřad pro kybernetickou bezpečnost a bezpečnost infrastruktury CISA ani Národní agentura pro bezpečnost (NSA) se k záležitosti bezprostředně nevyjádřily.
Generální ředitelka společnosti Luta Security Katie Moussourisová uvedla, že incident je předzvěstí budoucích útoků. Dnešní modely podle ní připomínají chobotnice s nekonečným množstvím chapadel schopných uchopit cokoli a protáhnout se téměř kamkoli. Laboratoře a vládní hodnotitelé musejí podle ní pracovat na tom, aby dokázali udržet pod kontrolou, monitorovat a informovat zasažené strany v případě, že AI provede nějaký další incident. Ideálně ale dříve, než to někomu způsobí problémy. "Dnes nic z toho neexistuje," uvedla.
Podle inženýra Matta Suicheho ze společnosti Tolmo incident ukázal, že nejpokročilejší modely snižují náskok a přibližují se schopnostem nejlepších útočníků. Zároveň ale řekl, že typy útoků popsané v blogovém příspěvku OpenAI lze provést pomocí technologií, které jsou dostupné i mimo zdi špičkových výzkumných laboratoří.
"Tohle už jsme interně viděli – u našich vlastních agentů už máme podobné výsledky,“ řekl Suiche. Jeho podnik se zabývá kybernetickou bezpečností založenou na autonomních agentech umělé inteligence. "Ani nemusíme používat nejnovější modely," dodal.
Jim Cramer, host of Mad Money, used his Tuesday morning appearance on CNBC’s “Squawk on the Street” on July 21, 2026 to fire a warning shot at investors who have ridden the AI trade to fresh highs and never taken a chip off the table. His message was blunt: “Because if you own too much tech, you’re going to be slaughtered. And you won’t even know what hit you. For the moment, it’s time to go to other sectors that can make you money without the volatility.”
With futures pointing higher on renewed semiconductor strength, Cramer wants investors to lean against the crowd and rotate proceeds into groups that have lagged the AI melt-up. The playbook: financials and healthcare, where valuations are cleaner and earnings power is showing up in results from banks that just reported.
The Discipline: Take Off Half When a Group Goes Red Hot Cramer’s rotation call is rooted in position sizing, not a top call on tech. “When you have a group that is red hot, you take off half. You have to be disciplined, and the reason why you have to be disciplined is because a lot of this last run, the parabolic move, is not cured by a 20% to 30% decline because the stock went up more than that.”
Micron Technology (NASDAQ:MU | MU Price Prediction) is Exhibit A. Cramer suggested a few weeks ago that investors sell half of Micron, and the numbers explain why. Shares are up 240.36% year to date and 758.78% over the past year. Fiscal Q3 2026 revenue landed at $41.456 billion, a 17.60% beat, with non-GAAP EPS of $25.11 versus $20.28 expected and GAAP gross margin expanding to 84.6% from 37.7% a year earlier. The fundamentals are real; the move is parabolic. Polymarket contracts currently price a 0.74 probability that Micron closes lower on July 22.
Where Cramer Sees Value: Banks at 12 to 15 Times Earnings The sector composition is already tilting. Among the top ten DOW names year to date, eight are either healthcare or financials. The July 14 bank earnings gave the rotation fresh fuel.
JPMorgan Chase (NYSE:JPM) posted Q2 EPS of $7.70 versus $5.80 expected on $57.35 billion in revenue, and authorized a fresh $50 billion buyback. Cramer’s take on Jamie Dimon: “You can buy his stock for 15 times earnings. It’s one of the brightest guys in the world. Jamie and his team is filled with brilliant people. 15 times. I’ll take it.” Shares are up 8.65% YTD.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Eli Lilly didn't make the cut. Grab the names FREE today.
Bank of America (NYSE:BAC) trades at 14 times earnings, delivered a fifth consecutive EPS beat at $1.21, and is up 13.34% YTD. Wells Fargo trades at 12 times earnings and remains -4.84% YTD, the kind of laggard Cramer is willing to buy while others chase memory chips.
Healthcare: Lilly the GLP-1 Winner Cramer’s second lane is pharma, and he wants the winner of the GLP-1 war. “I will say, you know what? Let me go and buy some Lilly into the Novo Nordisk weakness.”
Eli Lilly (NYSE:LLY) reported Q1 EPS of $8.55 versus $6.79 expected and revenue of $19.80 billion, up 55.5% YoY, then raised 2026 guidance to $82.0-$85.0 billion. Mounjaro alone did $8.66 billion, up 125%. Novo Nordisk, by contrast, is down 20.46% over the past year and guided full-year adjusted sales to a decline of 4% to 12% at constant currency.
The Takeaway Cramer’s message is about discipline. He wants investors to recognize when a move has run past what any normal pullback could fix, trim into strength, and redeploy where earnings are compounding at reasonable multiples. Banks reporting record quarters at 12 to 15 times earnings and a pharma leader raising guidance mid-year give him a place to put the profits. The discipline is the point.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Eli Lilly didn't make the cut. Grab the names FREE today.
The explosive growth of artificial intelligence (AI) has ignited a new supercycle in memory and storage chips. Training and running AI models demand enormous quantities of high-speed, low-latency memory to process massive data sets and parallel computations without bottlenecks.
Micron Technology (MU +12.26%) and Sandisk (SNDK +14.27%) have been prime beneficiaries of the AI memory boom thanks to their leadership in DRAM, NAND flash, and high-bandwidth memory (HMB). So far this year, Sandisk and Micron have surged 503% and 210%, respectively -- making them the top two performers in the Nasdaq-100.
While it may be tempting to follow the momentum, I think a harsh sell-off could be in store later this month. Read on to find out why.
Image source: The Motley Fool.
Why memory is becoming the bottleneck of AI workloads AI systems cannot function efficiently without high-performance memory. Frontier models shuttle billions of parameters and contextual data between processors at blistering speed. Insufficient DRAM bandwidth or storage capacity quickly becomes a limiting factor regardless of how powerful the underlying GPU clusters are.
Micron specializes in DRAM and HBM for training and real-time inference. Sandisk focuses on high-density NAND flash and enterprise-grade solid-state drives (SSDs) -- the storage foundation for vast data sets and model weights that power AI at scale. Both companies have ridden powerful tailwinds as AI hyperscalers race to expand capacity -- creating a structural shortage that has supported robust pricing power and earnings expansion.
Apple is pushing for more efficiency on its devices At the moment, there is no indication that Apple (AAPL +0.33%) will build its own memory fabs. Instead, the company continues to rely on external suppliers for its DRAM and NAND needs. However, recent reports suggest that Apple is exploring a collaboration with a company called PrismML, which specializes in memory compression.
The idea here is simple: Apple could use software optimizations to shrink AI models so they run more effectively on iPhones. By doing so, Apple can use memory quantization to slash memory cost requirements on select hardware while deploying the most demanding features on higher-end devices where component costs can be passed along to consumers in the form of price hikes.
Today's Change
(
0.33
%) $
1.06
Current Price
$
327.65
Taking a trip down memory lane Back in April, Alphabet released a product called TurboQuant, which promised major reductions in memory usage for AI inference. As the chart below shows, this announcement triggered an immediate sell-off in Micron and Sandisk stocks on fears that memory demand would evaporate.
MU data by YCharts
Investors can see that the sell-off was swift, yet the declines were ultimately short-lived. Both stocks quickly recovered and went on to notch fresh all-time highs as AI adoption continued to scale with higher overall memory and storage usage.
I think a comparable pattern could play out after Apple reports earnings on July 30. Any commentary about on-device AI progress or even rumors of proprietary memory protocols could spark short-term selling pressure in Micron and Sandisk as investors worry about reduced memory demand or new competition.
With that said, history suggests such a move would be overdone. Even if Apple improves its on-device capabilities or partners with memory-efficient providers, the fundamental need for HBM across the broader AI infrastructure stack is not going to diminish overnight. In fact, any advancement that Apple makes ultimately underscores the enduring importance and scarcity of advanced memory in the AI era. For this reason, any post-earnings weakness in Micron or Sandisk could represent a compelling opportunity to buy the dip.
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Zillow Group, Inc. (NASDAQ:Z, ZG) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from potential violations of the federal securities laws.
If you invested in Zillow, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/zillow-class-action-lawsuit.
Key Details of the Zillow ($Z, $ZG) Class Action:
Lead Plaintiff Deadline: August 10, 2026Alleged Misconduct: Securities fraud relating to Zillow’s allegedly anticompetitive agreement with Redfin CorporationLargest Alleged Stock Drop: February 11, 2026 – 16.54% Stock Drop on Class C shares; 17.13% Stock Drop on Class A shares.Court: U.S. District Court for the Western District of WashingtonAction: Contact BFA Law to discuss your rights
Investors have until August 10, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Zillow Class C and Class A common stock. The class action is pending in the U.S. District Court for the Western District of Washington. It is captioned Breidert v. Zillow Group, Inc., et al., No. 26-cv-02016.
Why is Zillow Being Sued for Securities Fraud?
On February 6, 2025, Zillow entered into an agreement with Redfin through which Zillow became the exclusive provider of multifamily rental listings on Redfin’s platform and affiliate websites, including Rent.com. According to the complaint, during the relevant period, Zillow characterized the agreement with Redfin as a “partnership” that would provide Zillow exclusive access to Redfin’s advertising platform.
As alleged, in truth, under the terms of the agreement, Zillow paid Redfin $100 million to stop competing with Zillow, facilitate the transition of its multifamily rental advertising business to Zillow, and close the remainder of its business.
Why did Zillow’s Stock Drop?
On September 30, 2025, the FTC filed a complaint against Zillow and Redfin alleging violations of the federal antitrust laws. According to the FTC complaint, “Zillow and Redfin executed an unlawful agreement to remove competition from [the online rental marketplaces industry], starting with a $100 million payment to Redfin to exit the [Internet Listing Services] market.” In sum, the FTC alleged, “[t]his agreement is nothing more than an end run around competition on the merits with Redfin for customers…” This news caused the price of Zillow’s Class C and A common stock to decline 4.33% and 4.5%, respectively.
On February 10, 2026, Zillow’s CFO told investors that Zillow experienced increased legal expenses which “will result in approximately 200 basis points headwind to EBITDA margins in Q1.” On this news, the price of Zillow’s Class C and A common stock declined 16.54%, and 17.13%, respectively.
Finally, on May 7, 2026, Reuters reported that a “federal judge rejected [Zillow and Redfin’s] request to end a [FTC] lawsuit accusing them of illegally agreeing to suppress competition for online apartment rental listings.” This news caused the price of Zillow’s Class C and A common stock to decline 1.9% and 1.76%, respectively.
Click here for more information: https://www.bfalaw.com/cases/zillow-class-action-lawsuit.
What Can You Do?
If you invested in Zillow, you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.
Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”
Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) today announces its 2026 second quarter results.1 "We delivered outstanding results in the second quarter, driving net revenues to over $11 billion for the first time with excellent growth across all headline metrics," said Jacek Olczak, Group CEO PMI. "With a robust first half under our belt, including continued momentum and strong results in our smoke-free business, we are well positioned to deli.
Packages of Marlboro cigarettes produced by Philip Morris International are seen at the grocery store in Warsaw, Poland May 29, 2024. REUTERS/Kacper Pempel Purchase Licensing Rights, opens new tab
CompaniesJuly 22 (Reuters) - Philip Morris International (PM.N), opens new tab cut its annual profit forecast for the third time this year on Wednesday, hurt by intensifying competition among tobacco products and negative currency swings.
Shares of the company were down 1% in premarket trading.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
The company also said it seeks to invest in its Zyn nicotine pouches following recent regulatory approval.
While U.S. regulators have recently taken a more favorable stance toward nicotine pouches, including allowing certain Zyn products to be marketed as less harmful than cigarettes, increased competition and pricing pressure have raised concerns about PMI's ability to maintain its market-leading position.
The company expects full-year adjusted earnings per share of $8.26 to $8.41, compared with its previous forecast of $8.31 to $8.46.
Philip Morris has been investing heavily to diversify beyond cigarettes, but faces mounting competition in the rapidly growing nicotine pouch category from products such as British American Tobacco's (BATS.L), opens new tab Velo.
The company launched Zyn Ultra, a higher-strength moist pouch variant, in June and priced it below PMI's flagship Zyn products on a per-pouch basis, as the company looks to defend market share.
Its second-quarter revenue rose 10.4% to $11.19 billion, exceeding analysts' estimate of $10.63 billion, according to data compiled by LSEG.
Reporting by Neil J Kanatt in Bengaluru and Emma Rumney in London; Editing by Devika Syamnath
Our Standards: The Thomson Reuters Trust Principles., opens new tab
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and certain of the company’s senior executives for securities fraud after significant stock drops resulting from potential violations of the federal securities laws.
If you invested in Regeneron, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/regeneron-class-action-lawsuit.
Key Details of the Regeneron ($REGN) Class Action:
Lead Plaintiff Deadline: September 14, 2026Alleged Misconduct: Securities fraud alleging that Regeneron misled investors regarding the success of its Phase III Fianlimab-Libtayo clinical trialStock Drop: April 29, 2026 – 6.2% Stock DropMay 15, 2026 – 9.8% Stock Drop Court: U.S. District Court for the Southern District of New YorkAction: Contact BFA Law to discuss your rights Investors have until September 14, 2026, to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Regeneron securities. The class action is pending in the U.S. District Court for the Southern District of New York. It is captioned Cheathem v. Regeneron Pharm., Inc., et al., No. 26-cv-6026.
Why is Regeneron Being Sued for Securities Fraud?
Regeneron is a pharmaceutical company that discovers, invents, develops, manufactures, tests, and commercializes medicines to treat various disorders.
During the relevant period, Regeneron was investigating Fianlimab, a human monoclonal antibody targeting the LAG-3 immune checkpoint receptor on T-cells. Specifically, Regeneron was testing Fianlimab in combination with Libtayo in a Phase III study to determine whether the drug combination could serve as a first-line treatment for advanced melanoma.
Regeneron told investors that it had “a lot of hope and confidence” that the Phase III trial “can generate a meaningful differentiation against current standards of care.” Further, despite acknowledging that study results had slowed, Regeneron told investors that this was likely because “there was a high level of response and those response[s] are very durable” and that the combination drug was a “potential blockbuster.”
In truth, as alleged, the Phase III Fianlimab-Libtayo study did not achieve statistically significant results.
Why did Regeneron’s Stock Drop?
On April 29, 2026, before market hours, Regeneron announced the Phase III Fianlimab-Libtayo study “will now consider all patients enrolled in the study with a minimum follow-up of 6 months.” This expansion of the study parameters indicated the study did not have enough positive results to achieve statistical significance. This news caused the price of Regeneron stock to decline $45.41 per share, or 6.2%, from a closing price of $731.77 per share on April 28, 2026, to $686.36 per share on April 29, 2026.
Then, on May 15, 2026, after market hours, Regeneron published a press release stating that the Phase III Fianlimab-Libtayo “did not reach statistical significance for the primary endpoint” tested. This news caused the price of Regeneron stock to decline $68.57 per share, or 9.8%, from a closing price of $698.25 per share on May 15, 2026, to $629.68 per share on May 18, 2026.
Click here for more information: https://www.bfalaw.com/cases/regeneron-class-action-lawsuit.
What Can You Do?
If you invested in Regeneron, you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.
Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”
Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
Investors comparing these two funds are really choosing between two different philosophies. The iShares Global Healthcare ETF (IXJ +0.60%) is a low-cost, diversified way to own the global healthcare sector. The Simplify Health Care ETF (PINK +1.49%) is an actively managed, more concentrated fund that includes innovative biotech and medtech names -- with a mission-driven twist that sets it apart from most other ETFs.
Snapshot (cost & size)MetricPINKIXJIssuerSimplifyiSharesExpense ratio0.51%0.40%1-year return (as of June 21, 2026)31.93%19.57%Dividend yield0.64%1.47%Beta0.780.52AUM$358.6 million$3.8 billionBeta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
IXJ is the more affordable option, with a 0.40% expense ratio compared to PINK's 0.51%. IXJ also pays out more for income-focused investors -- with a 1.47% dividend yield versus 0.64% for PINK.
Performance & risk comparisonMetricPINKIXJMax drawdown (3 yr)(18.77%)(18.14%)Growth of $1,000 over 3 years (total return)$1,449$1,187What's insideLaunched in 2001, the iShares Global Healthcare ETF (IXJ +0.60%) spreads its assets across 110 holdings covering the global healthcare sector. Its largest positions include Eli Lilly (LLY +2.30%) at 10.9%, Johnson & Johnson (JNJ +0.74%) at 7.0%, and Abbvie (ABBV +1.08%) at 5.1%.
The Simplify Health Care ETF (PINK +1.49%) takes a narrower, more concentrated approach, holding 58 positions. Its largest positions include Purecycle Technologies (PCT +6.08%) at 7.1%, United Therapeutics Corp (UTHR +1.23%) at 7.1%, and Novo Nordisk (NVO 0.41%) at 7.0%. PINK was launched in 2021.
For more guidance on ETF investing, check out the full guide at this link.
What this means for investorsChoosing between these two funds isn’t difficult. It really comes down to what an investor wants from their healthcare allocation.
IXJ is the more conventional choice -- a diversified index fund that's cheaper to own and pays a meaningfully higher dividend, making it a reasonable core holding for investors who want steady, low-maintenance exposure to global healthcare giants like Eli Lilly, Johnson & Johnson, and AbbVie.
PINK’s more concentrated portfolio comes with a mission-oriented mandate: Every dollar of net profit the fund generates is donated to breast cancer research through Susan G. Komen, one of the largest breast cancer non-profit organizations in the country. That's unique for an ETF -- most funds simply pocket their management fees -- so PINK gives investors a way to combine sector exposure with tangible social impact, without costing much more than a typical actively managed fund.
PINK has been the stronger performer lately, posting a roughly 32% one-year return -- well ahead of IXJ's steadier, more index-like results. That gap reflects the two funds' different approaches: PINK’s concentrated, actively managed portfolio includes more innovation-driven biotech and medtech names. These types of companies can outperform sharply at times, but that also means PINK carries more single-stock and strategy risk than a broadly diversified index fund. IXJ, by design, spreads risk across more than 100 global healthcare names, which tends to smooth out returns -- for better or worse -- compared with PINK's higher-octane approach.
Investors prioritizing income and diversification who want to keep costs as low as possible are likely better served by IXJ. Those comfortable with more concentration risk in exchange for the potential of stronger returns -- and who like the idea of their fund fees supporting cancer research -- may find PINK's offering more compelling. As always, recent outperformance is not a guarantee of what comes next, so investors should weigh their own risk tolerance as heavily as recent returns.
Andy Gould has positions in AbbVie, Novo Nordisk, and United Therapeutics. The Motley Fool has positions in and recommends AbbVie, Eli Lilly, Novo Nordisk, and United Therapeutics. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure policy.
Danaher’s businesses include biotechnology, diagnostics, and life sciences. The stock dropped after management narrowed its expectations for revenue growth. (Dreamstime)
To say Danaher Corp. had a downbeat reaction to earnings is an understatement. We regret the timing of our stock pick, though investors with longer time horizons will want to stay the course.
Texas Instruments Incorporated (NASDAQ:TXN) will release its second quarter earnings report after the closing bell on Wednesday, July 22.
Analysts expect the Dallas, Texas-based company to report quarterly earnings of $1.92 per share, up from $1.41 per share in the year-ago period. The consensus estimate for Texas Instruments’ quarterly revenue is $5.24 billion. It reported $4.45 billion last year, according to Benzinga Pro.
On July 16, the company’s board of directors declared a quarterly cash dividend of $1.42 per share.
Texas Instruments shares rose 2.6% to close at $291.30 on Tuesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
Considering buying TXN stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Intuit Inc. (NASDAQ:INTU) and certain of the company’s senior executives for securities fraud after significant stock drops resulting from potential violations of the federal securities laws.
If you invested in Intuit, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/intuit-class-action-lawsuit.
Key Details of the Intuit ($INTU) Class Action:
Lead Plaintiff Deadline: September 8, 2026Class Action Allegations: Securities fraud alleging that Intuit misled investors regarding TurboTax’s purported competitive advantages and growth prospectsLargest Alleged Stock Drop: May 21, 2026 – 20.02% Stock Drop Court: U.S. District Court for the Northern District of CaliforniaAction: Contact BFA Law to discuss your rights Investors have until September 8, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Intuit securities. The class action is pending in the U.S. District Court for the Northern District of California. It is captioned Baldwin v. Intuit Inc., et al., No. 26-cv-7086.
Why is Intuit Being Sued for Securities Fraud?
Intuit is a financial technology platform that serves consumers, small and mid-market businesses, and accountants through its offerings, which include TurboTax, Credit Karma, and QuickBooks.
During the relevant period, Intuit told investors it had significant “momentum” across its business segments, including TurboTax. Intuit attributed its “momentum” to purportedly significant competitive advantages, including integration of AI in its business and operations. Intuit also told investors that the 2026 tax season was “off to a strong start” as the company was poised to deliver the “best price for our customers.”
In truth, as alleged, the company was facing pressure among the most price-sensitive DIY tax filers and was not competitive on price in this segment.
Why did Intuit’s Stock Drop?
On May 20, 2026, before market hours, Reuters published an article titled “Intuit to cut 17% of global jobs to streamline operations, memo shows.” Reuters reported that Intuit was “laying off about 17% of its workforce” and was “winding down its Reno and Woodland Hills offices as part of a strategic restructuring to consolidate teams[.]” This news caused the price of Intuit stock to decline $15.78 per share, or 3.95%, from a closing price of $399.71 per share on May 19, 2026, to $383.93 per share on May 20, 2026.
Also on May 20, 2026, after market hours, Intuit released its fiscal Q3 2026 financial results, which included its 2026 tax season revenue. Intuit stated that it “did not have the overall tax season we expected” and that it “faced pressure among the most price-sensitive DIY filers.” Intuit stated that “[w]e [lost] on price.” Intuit also announced that TurboTax online paying units were expected to grow by only 2% as total IRS filers were expected to decline by approx. 30 basis points, representing the “most significant industry-wide contraction since the post-COVID tax season.” This news caused the price of Intuit stock to decline $76.86 per share, or 20.02%, from a closing price of $383.93 per share on May 20, 2026, to $307.07 per share on May 21, 2026.
Click here for more information: https://www.bfalaw.com/cases/intuit-class-action-lawsuit.
What Can You Do?
If you invested in Intuit, you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.
Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”
Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
Both American Airlines (NASDAQ:AAL | AAL Price Prediction) and Lockheed Martin (NYSE:LMT) report Q2 2026 results before the open on Thursday, July 23, 2026.
Food and beverage producer adopts on-machine architecture to reduce cabling, simplify maintenance and improve production visibility.
, /PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, modernizes end-of-line operations at Ken's Foods, improving performance, reducing complexity and supporting continued growth.
Legacy equipment, limited visibility and conveyor layouts that restrict material flow create inefficiencies across packaging and palletizing. Traditional cabinet-based automation architecture also slows maintenance, requiring technicians to access remote panels to troubleshoot.
Kens Foods Ken's Foods implements an on-machine architecture with Rockwell Automation PowerFlex 350 variable frequency drives (VFDs) accessible directly on production equipment, simplifying operations and delivering measurable gains:
Increased visibility: On-machine drives provide remote access to real-time current, voltage and speed data. Teams identify issues faster and improve end-of-line performance.
Simplified maintenance: Direct access to drives on the equipment reduces troubleshooting time and speeds replacement. Local disconnects, test points and quick-connect power and input/output (I/O) simplify lockout/tagout procedures and allow teams to isolate equipment without shutting down large sections of the line.
Reduced complexity: On-machine architecture cuts cabling, eliminates the need for large control panels and reduces engineering efforts. Conveyor-mounted drives shorten wire runs and simplify installation. Setup is intuitive, and commissioning moves quickly with minimal configuration delays.
"We estimate an overall cost savings of 17% compared to designing, building centralized panels and wiring directly to local motor disconnects, I/O points and motors," said Kyle Richard, vice president of business development for Elm Electrical, an electrical partner of Ken's Foods. "The on-machine VFDs also support a scalable safety system across a 130-drive palletizing line. A network-based safety architecture reduces wiring and panel costs and allows electronic stops to be placed where they are needed along the conveyors."
Based on the results, Ken's Foods establishes on-machine architecture as the standard for future pallet-conveying systems.
"This approach helps us operate more efficiently as demand grows," said Tony Stolo, project engineer, Ken's Foods. "It takes up less space, installs faster and is easier to maintain. It also gives us flexibility to expand or reconfigure as our operations evolve and reconfigure the system as our operations evolve."
Learn more about Rockwell Automation's on-machine portfolio and solutions for food and beverage manufacturing. Read more about Ken's Foods journey with Rockwell Automation here.
About Rockwell Automation
Rockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 26,000 problem solvers dedicated to our customers in more than 100 countries as of fiscal year end 2025. To learn more about how we are bringing the Connected Enterprise to life across industrial enterprises, visit www.rockwellautomation.com.
About Ken's Foods
Ken's Foods is a family-owned and -operated company that produces high-quality dressings, sauces and marinades. Ken's Foods, Inc was incorporated in 1958 and currently has plant operations in Marlborough, Massachusetts, McDonough, Georgia, Las Vegas and Lebanon, Indiana. In addition, Ken's employs over 1,600 employees nationally. Today, between its Retail Grocery Products and Food Service divisions, Ken's Foods produces and packages over 400 varieties of dressings and sauces. For more information, visit www.kensfoods.com.
View of the Prologis warehouse in Nieuwegein, Netherlands in this undated handout obtained by Reuters on November 30, 2020. Courtesy of Prologis/Handout via REUTERS/File Photo Purchase Licensing Rights, opens new tab
SummaryCompaniesBest and final bid of £10.32 per Segro shareSeveral investors had called on companies to engage furtherSegro shares up more than 4%July 22 (Reuters) - U.S. warehousing giant Prologis (PLD.N), opens new tab on Wednesday made what it called its best and final proposal to buy British rival Segro (SGRO.L), opens new tab for about £14 billion ($18.8 billion), in a last-minute approach ahead of a takeover deadline as investors urged the pair to keep talking.
Shares in Segro rose more than 4% to £9.07 by 0936 GMT but remained below the new bid price of £10.32 per share.
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
The offer comprises 0.0920 Prologis shares and a partial cash alternative of up to £3.5 billion, marking an improvement from the company's third proposal, which Segro rejected on Monday.
"The Best and Final Proposal is final and will not be increased," Prologis said in a statement, although it added that it could still choose to do so under some exceptional conditions.
Investors including APG Asset Management, Norges Bank and CCLA Investment Management urged the companies to engage in talks, saying a combination was valuable and merited consideration.
Prologis' latest proposal represents a roughly 45% premium to the group's closing price on June 23, the day before Prologis first went public with its interest.
"We met and engaged with Prologis over the weekend and have been clear that we would consider and engage again on a revised proposal," a Segro spokesperson said in a statement emailed to Reuters shortly before Prologis' improved bid was announced.
The British group did not immediately respond to a further request for comment on the latest offer.
($1 = 0.7478 pounds)
Reporting by Prerna Bedi, Pushkala Aripaka, Anushka Chourasia and Nithyashree R B in Bengaluru; Editing by Subhranshu Sahu, Kirsten Donovan
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Prologis—the world's largest owner of industrial real estate—made a 9.5% increase over its initial proposal to take over its smaller U.K. rival, but ruled out further increases.
SEGRO PLC (LSE:SGRO) shares jumped as US logistics property giant Prologis Inc (NYSE:PLD) raised its bid in what it described as a "best and final" offer, and called for a longer deadline for negotiations.
The revised proposal values the FTSE 100 property group at around £14 billion, with shareholders offered 0.092 new Prologis shares for each Segro share – a 9.5% improvement on its initial approach – plus a £3.5 billion partial cash alternative.
Based on the closing share price of the US company, the offer values Segro at 1,031.7p per share, representing a 39% premium to Segro's closing price before the offer period began and a 14% premium to its adjusted net asset value at the end of June.
On Monday, Segro's board rejected a third approach priced at 993p a share, or about £13.5 billion, after meeting members of Segro's management in London over the weekend.
Yesterday, Prologis released a combative statement, saying no credible path to a recommended deal had been found, and accusing the Segro board of relying on an aspirational valuation built on unrealistic assumptions.
Prologis chief executive Dan Letter said the company had responded to shareholder feedback by improving its proposal but stressed the revised terms represented its final offer.
"We have listened to feedback from shareholders and this morning, we have improved our proposal to make a compelling offer to the Segro board," he said.
The US group has also asked Segro to seek an extension to the "put up or shut up" deadline, currently set to expire at 5pm today, to allow more time to negotiate the remaining terms of a recommended deal.
If completed, existing Segro shareholders would own about 8.9% of the combined company. Prologis also said it would explore a secondary listing in London if there is sufficient investor demand.
Silver (XAG/USD) trades around $59.35 at the time of writing on Wednesday, up 0.94% on the day, as persistent safe-haven demand offsets the negative impact of rising inflation expectations. The white metal remains supported by escalating geopolitical tensions in the Middle East, even as the sharp rebound in Oil prices reinforces expectations that major central banks may need to keep monetary policy restrictive for longer.
West Texas Intermediate (WTI) Oil extends its rally to around $86.60 per barrel after the closure of the Bab el-Mandeb Strait intensified concerns over global energy supplies. The waterway represents a key route for global energy shipments, and the latest disruption has reignited fears of supply shortages. According to BBC News, Yemen's Iran-backed Houthi movement announced a maritime embargo against Saudi Arabia in retaliation for the Saudi blockade of ports and airports in Houthi-controlled areas.
Higher energy prices are increasing concerns about a new wave of inflation, a development that could encourage central banks to maintain restrictive monetary policies. Such an environment would normally weigh on non-yielding assets such as Silver by pushing bond yields higher.
However, investors continue to favor precious metals as geopolitical uncertainty boosts demand for defensive assets. The conflict between the United States (US) and Iran, together with mounting risks to global energy flows, has supported inflows into traditional safe havens, helping Silver remain resilient despite the headwind from rising rate expectations.
Looking ahead, market participants will closely monitor Thursday's European Central Bank (ECB) monetary policy decision. While policymakers are widely expected to leave interest rates unchanged, investors will focus on comments from ECB President Christine Lagarde for fresh clues on the inflation outlook and the future path of monetary policy.
Silver FAQs Silver is a precious metal highly traded among investors. It has been historically used as a store of value and a medium of exchange. Although less popular than Gold, traders may turn to Silver to diversify their investment portfolio, for its intrinsic value or as a potential hedge during high-inflation periods. Investors can buy physical Silver, in coins or in bars, or trade it through vehicles such as Exchange Traded Funds, which track its price on international markets.
Silver prices can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can make Silver price escalate due to its safe-haven status, although to a lesser extent than Gold's. As a yieldless asset, Silver tends to rise with lower interest rates. Its moves also depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAG/USD). A strong Dollar tends to keep the price of Silver at bay, whereas a weaker Dollar is likely to propel prices up. Other factors such as investment demand, mining supply – Silver is much more abundant than Gold – and recycling rates can also affect prices.
Silver is widely used in industry, particularly in sectors such as electronics or solar energy, as it has one of the highest electric conductivity of all metals – more than Copper and Gold. A surge in demand can increase prices, while a decline tends to lower them. Dynamics in the US, Chinese and Indian economies can also contribute to price swings: for the US and particularly China, their big industrial sectors use Silver in various processes; in India, consumers’ demand for the precious metal for jewellery also plays a key role in setting prices.
Silver prices tend to follow Gold's moves. When Gold prices rise, Silver typically follows suit, as their status as safe-haven assets is similar. The Gold/Silver ratio, which shows the number of ounces of Silver needed to equal the value of one ounce of Gold, may help to determine the relative valuation between both metals. Some investors may consider a high ratio as an indicator that Silver is undervalued, or Gold is overvalued. On the contrary, a low ratio might suggest that Gold is undervalued relative to Silver.
Treasury Secretary Scott Bessent told reporters Tuesday that the CLARITY Act, the market-structure bill that would formally classify XRP and Bitcoin as digital commodities, is on the “1-yard line” in the Senate, and he urged lawmakers to finish the job before the chamber breaks for its August recess. The Bessent quote and broad market reaction were carried by Bloomberg and Stocktwits on July 21, 2026. For XRP holders, this is the closest Washington has come to permanently settling the question that has hung over the token since the SEC first sued Ripple in 2020.
The reaction was immediate. XRP traded to an intraday high of $1.1511 and settled near $1.1485, a 3.5% gain, with roughly $2.93 million in leveraged short positions liquidated, making it the third-best performer among the top 50 cryptocurrencies on the day. Our own data pegs XRP at $1.14 as of July 22.
What Actually Changed The breakthrough was political, not technical. President Trump agreed to the CLARITY Act’s ethics provision, which bars the president, vice president, lawmakers, and senior officials from personally profiting from crypto while in office. That clause had stalled the bill for months. Trump’s own crypto ventures, including meme coin royalties and World Liberty Financial token sales, reportedly netted him more than $1.2 billion in 2025 alone (per Yahoo Finance/Decrypt reporting), which is why Democrats had refused to move without guardrails.
The backstory matters. Senator Chris Van Hollen’s earlier amendment to bar officials and their families from owning or promoting crypto was blocked by Republicans in May. The bill cleared the Senate Banking Committee 15 to 9, with only two Democrats, Ruben Gallego and Angela Alsobrooks, voting yes. The unlock came after Trump met with Senators Cynthia Lummis and Bernie Moreno.
The Vote Math Is Still Tight Republicans hold 53 Senate seats; passage requires 60 votes, so at least seven Democrats must cross over. Key holdouts include Catherine Cortez Masto and Mark Warner, who reportedly want illicit-finance safeguards addressed first. Prediction traders are not yet convinced: Polymarket’s implied probability of the CLARITY Act being signed into law in 2026 sits around 41%, having climbed into the low-40s from the low-30s.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Coinbase didn't make the cut. Grab the names FREE today.
The rally extended beyond XRP. Bitcoin traded around $66,800, and Coinbase (NASDAQ:COIN | COIN Price Prediction) closed at $175.85 on July 21, up 9.61% on the session and 8.89% for the week. That still leaves the stock down 22.24% year to date, a reminder that 2026 has been brutal for the crypto complex. Market cap now sits at roughly $42.27 billion.
The Case for Caution Not everyone is celebrating. Senators Van Hollen and Elizabeth Warren argue the current draft “risks deregulating existing markets and opening the door to further corruption and abuse” rather than strengthening consumer protections. And the clock is real: Senate Majority Leader John Thune must still fit a floor vote into a narrow window before the August 7 recess. Even a signed bill would be, in Bessent’s framing, a catalyst rather than a finish line. The GENIUS Act, the 2025 stablecoin law, is the cautionary tale: regulators later missed a follow-up rulemaking deadline.
For XRP, the single biggest overhang on institutional adoption, the risk that its commodity status could be reversed by a future administration, just moved meaningfully closer to permanent resolution. Whether it clears the Senate before August, and whether the final text satisfies its Democratic critics, is the drama still to come.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Coinbase didn't make the cut. Grab the names FREE today.
